INN: 2-phase insulin (human genetically engineered), a suspension for subcutaneous injections.
Dosage form: genetically engineered human insulin mix (30/70).
Therapeutic (hypoglycemic) effect: after 30 minutes.
The maximum effect: after 4-12 hours.
Duration: up to 24 hours.
Production forms: bottles - 5ml x 5pcs, cartridges - 3ml x 5pcs, disposable syringe pens - 3ml x 5pcs.
